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e-mail address: algarui@yahoo.com (A. Galvez-Ruiz).Alberto Galvez-Ruiz a,c,⇑, Sawsan R. Nowilaty bAbstractThe term intermediate uveitis (IU) refers to a subgroup of uveitis in which the vitreous is the site of greatest inflammation. Patients
with multiple sclerosis (MS) have a greater frequency of IU compared with the general population.
The IU associated with MS is characterized by the presence of pars planitis (occasionally accompanied by anterior uveitis) and the
presence of peripheral retinal vasculitis in the form of periphlebitis (venous sheathing) in 6–26% of patients.
We present a patient with an unusual initial presentation of MS involving central retinal artery occlusion (CRAO) in the right eye
(RE).
Although retinal vascular changes are asymptomatic in the majority of MS patients, the spectrum of impairment ranges from
simple peripheral retina periphlebitis to the presence of peripheral occlusive retinal vasculitis in 6.5% of patients.
This atypical case may represent an extreme of the spectrum of retinal vasculitis associated with demyelinating disease.
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The term intermediate uveitis (IU) refers to a subgroup of
uveitis in which the vitreous is the site of greatest inflamma-
tion. When IU is accompanied by snowbanks or snowballs,
the condition is referred to as pars planitis.1
Patients with IU may present with inflammation in the
anterior chamber (which is generally minimal) and peripheral
vascular sheathing.1,2
Patients with multiple sclerosis (MS) have a greater
frequency of IU compared with the general population.
According to the publications we consulted, between 0.4%
and 26.9% of patients with MS develop uveitis, and between
7.8% and 14.8% of patients with IU develop MS.1,3 However,
other diseases are associated with IU, including Lyme
disease, syphilis, cat scratch disease, and sarcoidosis.1We present a patient with an unusual initial presentation
of MS involving central retinal artery occlusion (CRAO) in
the right eye (RE). This highly atypical case may represent
one extreme of the retinal vasculitis spectrum associated with
demyelinating diseases.Case report
We present a 46-year-old woman who was admitted to the
emergency room in 2010 with a sudden decrease in the RE
visual acuity (VA), which had an onset several hours prior.
She had mild pain with eye movement. The patient did not
have a relevant medical history and was medicated only with
oral contraceptives.
In the emergency room, the blood pressure was 101/67,
and the examination revealed a VA of 6/200 in the RE ande:
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15 mmHg in the RE and 14 mmHg in the LE.
The pupils were isochoric and normoreactive to light and
accommodation, but with the presence of a relative afferent
pupillary defect in the RE. The slit lamp revealed RE conjunc-
tival ciliary injection and the presence of mild inflammation,
1+ cells, and flare in the anterior chamber. There were no
posterior synechiae.
Conspicuous in the fundus of the eye was a hyperemic,
slightly elevated optic disk, with ischemic pallor of the retina
at the posterior pole that was compatible with acute CRAO
and a preserved cilioretinal artery (Fig. 1A). Likewise, there
was vascular sheathing and vitritis with snowballs.
The fluorescein angiogram showed mild signs of retinal
vasculitis, retinal arterial filling delay, diffuse retinal capillary
non-perfusion in the posterior pole compatible with CRAO.
Preservation of the retinal circulation around the cilioretinal
artery was visible, as was contrast leakage from the optic disk
in the subsequent frames (Fig. 1B–C). The macular optical
coherence tomography (OCT) showed increased retinal
reflectivity consistent with CRAO (Fig. 2).
Given the presence of typical periventricular demyelinating
lesions (some showing contrast uptake) in the cranial and orbi-
tal MRI, as well as slight enhancement of the optic nerve after
contrast injection, it was believed that the patient might have
had optic neuritis in addition to uveitis (Fig. 3). Consequently,
treatment was initiated with intravenous methylprednisolone,
1 g every 24 h for three days (single dose), followed by a
tapered oral dose (1 mg/kg tapered gradually in 2 weeks).
Likewise, topical treatment was initiated using a corticoste-
roid in the RE (prednisolone acetate drops three times a
day, gradually reducing the dose in 4 weeks).
Upon ophthalmologic examination two months later, the
VA was 20/50 in the RE and 20/20 in the LE. There was no
inflammation in the anterior chamber, and the fundus of the
RE displayed global pallor of the optic nerve with retinal
arteriolar attenuation at the posterior pole. The neurological
examination was normal. The VA improvement was believed
to be caused by the decreased in macular thickening or optic
neuritis improvement after corticosteroid treatment.
The requested blood analyses, which included C-reactive
protein (CRP), Anti-nuclear Ab (ANA), Anti-DNA, Treponema
pallidum hemagglutination assay (TPHA), Rapid Plasma Rea-
gin (RPR), Angiotensin converting enzyme (ACE), serum Lyso-
zyme, and coagulation risk profile, were all within normal
limits. Likewise, a chest CT scan, purified protein derivative
(PPD), EKG, echocardiogram, and Doppler of the carotids
were obtained, with results within normal limits.
Goldmann’s visual field revealed a residual central and
temporal islet in the RE and normal findings in the LE (Fig. 4).
During two years of follow-up, the patient remained clini-
cally stable. However, the appearance of new periventricular
lesions on subsequent MRIs, combined with the suspicion of
initial optic neuritis, has led to the diagnosis of MS and the
initiation of treatment with interferon beta-1 by the Neurol-
ogy Service (Fig. 5).Discussion
We present a patient with an unusual initial presentation
of MS combining a CRAO with a possible optic neuritis in
the RE. Such an atypical case may represent one extremeof the retinal vasculitis spectrum associated with demyelinat-
ing disease.
The IU associated with MS is characterized by the presence
of pars planitis (occasionally accompanied by anterior uveitis)
and the presence of peripheral retinal vasculitis in the form of
periphlebitis (venous sheathing) in 6–26% of patients.3
In the majority of patients, these retinal vessel changes are
asymptomatic. Regardless, certain studies have shown that
the presence of peripheral vascular disease in a patient with
isolated sheathing in typical optic neuritis may predict the
development of MS in the future, with a relative risk of
11.4%.4,5 Other studies have linked the presence of vascular
sheathing with the severity of the neurological dysfunction in
MS patients.3,6
Nonetheless, despite the fact that in the majority of
patients, these retinal vascular changes are asymptomatic,
there are numerous publications demonstrating a spectrum
that ranges from simple peripheral retinal periphlebitis to
the presence of peripheral occlusive retinal vasculitis in 6.5%
of patients.1,4,7 This condition leads to other complications,
such as retinal ischemia, neovascularization, retinal detach-
ment, vitreous hemorrhage,2 or neovascular glaucoma.8
This patient belongs within the group of patients with
occlusive retinal vasculitis associated with demyelinating
disease. However, this case is unusual in that the intense
retinal vasculitis was associated with CRAO.
The pathogenic mechanism that occurs in retinal vasculitis
is that of infiltration of the retinal venules by T-cell lympho-
cytes, of which 35–90% are CD4+.1
Recent immunogenetic studies have revealed that the
HLA-DR15 allele may encode a predisposition for the devel-
opment of MS and pars planitis, which demonstrates that the
processes share a similar immunopathogenic substrate.9,10
In patients for whom MS and IU are associated, MS tends
to be the first disease to present clinically. Thus, in the study
by Biousse,3 neurological symptoms occurred nine years
prior to the start of uveitis in 57.1% of cases. In addition, only
one patient in the study had an initial presentation with simul-
taneous ocular and neurological symptoms.
Our patient’s visual symptoms led to the diagnosis of MS
through a cranial MRI, which showed typical demyelinating
lesions. However, she had not previously presented with
neurological symptoms.
With respect to the differential diagnosis of occlusive
retinal vasculitis, in addition to the demyelinating etiology,
we must consider sarcoidosis, Behçet’s disease, and tubercu-
losis. Additionally, as in MS, all of these diseases may alter
the central nervous system (for example, neuro-Behçet and
neuro-sarcoidosis), thus further complicating the differential
diagnosis in certain cases.8
A study conducted in Tunisia described 18 patients with
CRAO secondary to posterior uveitis. The most frequent eti-
ology was toxoplasmosis, followed by rickettsiosis and
Behçet’s disease. There were no patients with demyelinating
disease, and only one patient presented with an idiopathic
etiology.11 Similar studies have shown that the presence of
CRAO associated with MS is infrequent. Nonetheless, there
are publications in which the presence of CRAO and branch
retinal artery occlusion (BRAO) is described in optic neuritis
patients, with similar frequencies from demyelination versus
post-vaccination.12–15
In the study by Kahloun et al., various mechanisms are pro-
posed to explain the occurrence of retinal arterial occlusions
Figure 1. (A) Fundoscopy in which the presence of a slightly hyperemic RE optic disk is prominent, with retinal ischemic pallor in the posterior pole,
compatible with acute CRAO and a preserved cilioretinal artery. (B–C) Fluorescein angiography showing delay in the retinal arterial filling and diffuse
retinal capillary non-perfusion at the central and temporal macula compatible with CRAO. The retinal circulation in the cilioretinal artery’s territory is
preserved. The retinal vessels stain in later frames. Dye leakage at the optic disk in the context of uveitis is observed.
Figure 2. Optical coherence tomography (OCT) shows increased reflectivity of the neurosensory retina at the temporal macula, typical of acute CRAO
(top image). The left macular scan is normal (bottom image).
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Figure 3. Cranial and orbital MRI showing the presence of typical demyelinating periventricular lesions (some of them with contrast enhancement), along
with slight enhancement of the optic nerve after contrast injection (coronal and axial T1 sequence after contrast injection).
Figure 4. Goldmann’s visual field test revealing a residual central and temporal island in the RE and a normal LE.
Figure 5. Cranial MRI performed two years later showing the presence of typical demyelinating periventricular and pericallosal lesions (some of them
with contrast enhancement) (axial T2, sagittal FLAIR and axial T1 sequence after contrast injection).
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retinitis or chorioretinitis focus, arteriolar constriction due to
neurotransmitter secretion by mast cells in response to the
inflammatory stimulus, and infiltration of the vascular wall by
inflammatory cells, causing a secondary arterial thrombosis.11
However, in MS patients with associated optic neuritis and
retinal vasculitis, some authors propose a mechanism of
vessel compression secondary to optic nerve inflammation.
Relevant studies include the investigation by Akarsu et al.,16in which the retrobulbar hemodynamics were measured in
patients with MS and optic neuritis, demonstrating hemody-
namic worsening in the central retinal artery and in the
posterior ciliary arteries. These authors propose that patients
with optic neuritis might exhibit direct compression of
the blood vessels inside the scleral canal. Alternatively,
vasospasm might be produced secondary to an increase in
plasma endothelin-1, which may act as a potent vasoconstric-
tor, thereby leading to increased blood flow resistance.
164 A. Galvez-Ruiz, S.R. NowilatyOur patient also presented optic nerve impairment, as
enhancement was observed on the MRI after contrast injec-
tion. It is questionable whether this finding represented optic
neuritis or, rather, edema of the optic nerve secondary to
uveitis. Thus, although we believe that the fundamental
mechanism of the vascular occlusion was inflammatory, we
cannot rule out compression of the central retinal artery as
it passed through the optic nerve head.
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